# Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin

> **NCT01638988** · PHASE3 · WITHDRAWN · sponsor: **Clinique Ovo**

## Conditions studied

- Polycystic Ovary Syndrome
- Insulin Resistance

## Interventions

- **DRUG:** Metformin
- **DRUG:** Clomiphene citrate

## Key facts

- **NCT ID:** NCT01638988
- **Lead sponsor:** Clinique Ovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-09
- **Primary completion:** 2013-11
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Previous studies have been done regarding same condition
- **Last updated:** 2015-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638988, "Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT01638988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*